Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer

NCT00585689 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: ABI-007
DRUG: Carboplatin
DRUG: Gemcitabine
PROCEDURE: Radical Cystectomy

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]